Researchers from an Indiana University School of Medicine-led consortium of Alzheimer’s disease experts are studying how an anti-seizure drug used to treat epilepsy in children and adults could be repurposed as a potential therapeutic for Alzheimer’s disease.
Researchers at Indiana University School of Medicine are celebrating Federal Drug Administration approval of teplizumab, a new immunotherapy drug that delays the onset of type 1 diabetes in at-risk individuals by an average of almost three years.
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.
Researchers at Indiana University School of Medicine are studying new ways to predict to prevent suicidality. The team recently published findings about the effectiveness of a new risk assessment tool in the Springer Nature journal Discover Mental Health.
Some patients in Indiana are now able to receive new screenings for early detection of Alzheimer’s disease thanks to a pilot program at Indiana University School of Medicine and Indiana University Health.